Founder Profile
George Merck
Last reviewed: 2026 · By Swet Parvadiya
Background
George Merck was a German-born businessman who emigrated to the United States in the late nineteenth century to establish and manage the American subsidiary of E. Merck of Darmstadt, Germany — the pharmaceutical and chemical company that his family had founded and developed over generations. His role in the United States was initially that of a representative agent for German pharmaceutical exports, but he gradually built the American operations into a genuine manufacturing and commercial enterprise rather than merely an import business. When U.S. Government wartime policy severed the connection to the German parent in 1917, George Merck's position as the in-place management team gave him the opportunity to acquire and independently operate what would become one of the most scientifically consequential pharmaceutical companies in American history.
Founding Story
George Merck established Merck & Co. As the American subsidiary of E. Merck of Darmstadt, Germany in 1891, tasked with managing the distribution and eventual domestic manufacture of pharmaceutical and chemical products in the rapidly expanding American market. Under his management in the 1890s and 1900s, the American business grew from a pure import operation into a domestic manufacturer with facilities in Rahway, New Jersey. The forced separation from the German parent company during World War I — when the U.S. Government seized German-owned American business assets under the Trading with the Enemy Act — created the opportunity for George Merck to purchase the confiscated business and reconstitute it as an independent American corporation in 1919. His son George W. Merck subsequently led the company through its most scientifically productive era in the mid-twentieth century, articulating the 'medicine is for the people' philosophy that became the foundation of Merck's research culture and corporate identity. The Merck family's involvement in the company's management diminished after the mid-twentieth century as professional pharmaceutical executives succeeded the founding lineage.